Key result
JC70 antibody stains malignant endothelial cells in angiosarcoma more consistently than FVIII-Rag.
Observational
Answers are grounded in this paper and cite their sources.
A new monoclonal antibody, JC70, raised against a membrane preparation from a spleen affected by hairy cell leukaemia, recognises a membrane bound glycoprotein identical with that of the CD31 group of monoclonal antibodies. The antibody stains a fixation resistant epitope on endothelial cells in benign and malignant conditions in a wide variety of paraffin wax embedded tissue. JC70 stained malignant endothelial cells in 10 angiosarcomas with more consistency than monoclonal or polyclonal antibodies to factor VIII related antigen (FVIII-Rag). In four cases of Kaposi's sarcoma the antibody stained malignant endothelial cells but not spindle cells. It is concluded that antibody JC70 is of value for studying benign and malignant human vascular disorders in routinely processed tissue.
No takes yet. Share an insight, caveat, or question.
Parums et al. (1990) conducted an observational in Benign and malignant vascular disorders (including angiosarcoma and Kaposi's sarcoma). JC70 monoclonal antibody staining vs. Monoclonal or polyclonal antibodies to factor VIII related antigen (FVIII-Rag) was evaluated on Immunohistochemical staining of malignant endothelial cells. JC70 monoclonal antibody stained malignant endothelial cells in 10 angiosarcomas more consistently than FVIII-Rag antibodies, and stained endothelial cells in 4 Kaposi's sarcoma cases.
Synapse has enriched 10 related papers. Consider them for comparative context: